Offer - Urjas Oil for just ₹ 1 X
Baidyanath Nagpur Shrigopal Taila is an ayurvedic medicine that is primarily used for the treatment of Weakness. Secondary and off-label uses of Baidyanath Nagpur Shrigopal Taila have also been mentioned below. The key ingredients of Baidyanath Nagpur Shrigopal Taila are Nagkesar, Shankhpushpi, Sesame Oil, Bay leaf, Nagabala. The properties of which have been shared below. The correct dosage of Baidyanath Nagpur Shrigopal Taila depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Nagkesar |
|
Shankhpushpi |
|
Sesame Oil |
|
Bay leaf |
|
Nagabala |
|
Baidyanath Nagpur Shrigopal Taila 25ml is used to treat the following -
Main Benefits
Other Benefits
No side effects of Baidyanath Nagpur Shrigopal Taila have been reported in the medical literature. However, you should always consult your doctor before using Baidyanath Nagpur Shrigopal Taila.
Is the use of Baidyanath Nagpur Shrigopal Taila 25ml safe for pregnant women?
Baidyanath Nagpur Shrigopal Taila is not recommended to women. So, women should talk to a doctor before taking it.
Is the use of Baidyanath Nagpur Shrigopal Taila 25ml safe during breastfeeding?
Generally, doctors do not prescribe Baidyanath Nagpur Shrigopal Taila to women. So, women should not use it consulting a doctor first.
Is the use of Baidyanath Nagpur Shrigopal Taila 25ml safe for children?
Baidyanath Nagpur Shrigopal Taila is not considered safe for children.
This medicine data has been created by -
BAMS, Gastroenterology, Dermatology, Psychiatry, Ayurveda, Sexology, Diabetology
10 Years of Experience
References
Ministry of Health and Family Welfare. Department of Ayush: Government of India. [link]. Volume 2. Ghaziabad, India: Pharmacopoeia Commission for Indian Medicine & Homoeopathy; 1999: Page No - 125 - 126
Ministry of Health and Family Welfare. Department of Ayush: Government of India. [link]. Volume 2. Ghaziabad, India: Pharmacopoeia Commission for Indian Medicine & Homoeopathy; 1999: Page No 155 - 157